Millie
your market intelligence analyst
Search Results
Edit Save
100 results
Breast Cancer News 10/16/2019 12:44
Kisqali (ribociclib) in combination with Faslodex (fulvestrant) prolongs the survival of postmenopausal women with HR-positive, HER2-negative, advanced or metastatic breast cancer, interim analysis of a Phase 3 clinical trial shows. The findings were presented in a late-breaking presentation titled, “Overall survival (OS) results of the phase III MONALEESA-3 trial of postmenopausal patients (pts) with hormone […]. .
Breast Cancer News 10/09/2019 08:42
In observance of National Breast Cancer Awareness Month, the Los Angeles oceanfront resort Terranea will again “turn pink” to benefit breast cancer organizations. Throughout October, Terranea will — for the fourth year — reprise its “Terranea Turns Pink” initiative, which donates a portion of proceeds from golf rounds, special cocktails, spa treatments, desserts, room stays, […]. .
Breast Cancer News 10/07/2019 11:41
Veliparib in combination with chemotherapy significantly prolongs survival without disease progression in women with metastatic HER2-negative breast cancer with BRCA mutations, compared with women on chemotherapy alone, a Phase 3 trial shows. The trial’s findings were presented in a session, titled “Phase 3 study of veliparib with carboplatin and paclitaxel in HER2-negative advanced/metastatic gBRCA-associated breast […]. .
Breast Cancer News 10/02/2019 13:30
Marking 20 years of support for breast cancer awareness and research, Hard Rock International has kicked off a host of efforts for its annual “PINKTOBER” campaign. Presented every October in observance of Breast Cancer Awareness Month, Hard Rock’s cafes, hotels, casinos and Rock Shops will raise money for the Hard Rock Heals Foundation, Hard Rock’s charitable arm, […]. .
Breast Cancer News 09/30/2019 14:04
The first patients have been dosed in a Phase 1 trial evaluating Arvinas‘ experimental therapy ARV-471 for locally-advanced or metastatic ER-positive, HER2-negative breast cancer. Approximately 80% of newly-diagnosed breast cancers produce a protein called an estrogen receptor (ER). In these cancers, the hormone estrogen binds to its receptor, causing the cells to grow and multiply. […]. .
Breast Cancer News 09/27/2019 10:20
The U.S. Food and Drug Administration has approved Mylan‘s generic version of AstraZeneca‘s Faslodex injection to be used for the same breast cancer indications as the original product, the company announced. The approval makes Mylan‘s Fulvestrant injection the third generic version of Faslodex, following the approval of Sandoz‘s and Glenmark Pharmaceuticals‘ products. A generic version […]. .
Breast Cancer News 09/25/2019 05:27
Because access to prior mammograms is critical for women during all stages of breast health, Life Image is offering free membership during October — Breast Cancer Awareness Month — to its unique health management platform. At the same time, the global network for sharing clinical and imaging data is launching “My Data, My Rights,” a […]. .
Breast Cancer News 09/18/2019 10:54
The 2019 Lasker-DeBakey Clinical Medical Research Award has been granted to scientists H. Michael Shepard, PhD, Dennis J. Slamon, MD, PhD, and Axel Ullrich, PhD, for their development of the breast cancer therapy Herceptin (trastuzumab). The Lasker Awards are widely regarded as America’s most prestigious biomedical research awards and have been honoring key contributions to the understanding, […]. .
Breast Cancer News 09/16/2019 06:35
A metastatic triple-negative breast cancer (TNBC) patient is being treated with CytoDyn’s investigational leronlimab (PRO 140) under an emergency investigational new drug (IND) application granted by the U.S. Food and Drug Administration, An emergency IND can be used by physicians to request permission to give an investigational medication to a person with a life-threatening condition, [...]. .
Breast Cancer News 09/10/2019 10:00
1: Number of times a doctor told me, “Best-case scenario, you’ll be stuck with a ‘frankenboob.’ ” 0: Odds a doctor gave me that I’d be able to get chemo in time to save my life. 3: Months a doctor predicted I’d live. 10: Age of my daughter when I got this prognosis. 9,342: Number of miles I […]. .
Breast Cancer News 09/09/2019 12:31
The U.S. Food and Drug Administration (FDA) has granted orphan drug status to Puma Biotechnology’s Nerlynx (neratinib) for the treatment of HER2-positive breast cancer in women with brain metastases. Between 10 to 15% of people with metastatic breast cancer develop brain metastases. However, that number reaches up to 30% in women with advanced HER2-positive breast cancer. Orphan drug designation […]. .
Breast Cancer News 09/06/2019 09:43
The longer women use hormone therapy after menopause the higher is their breast cancer risk over time, and this risk persists for more than a decade after stopping this replacement therapy, a new meta-analysis suggests. “Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence” was […]. .
Breast Cancer News 09/04/2019 09:40
The U.S. Food and Drug Administration (FDA) has drafted a series of recommendations urging the inclusion of men in breast cancer clinical trials, aiming to broaden treatment options for these patients. Men are rarely included in clinical trials assessing the effectiveness of medications to treat breast cancer because the incidence of this particular type of […]. .

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications